Selective Decrease of Serum Immunoglobulin G1 as Marker for Early Stages of Invasive Breast Cancer
Authors:
- 1 November 2000
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 64 (2) , 193-199
Abstract
The diagnostic value of the decrease in percentage of immunoglobulin G1 (%IgG1) in breast cancer was analyzed with special emphasis on early tumor stages. IgG1 and total IgG were preoperatively...Keywords
This publication has 13 references indexed in Scilit:
- The tumor-associated shift in immunoglobulin G1/G2 is expressed at the messenger RNA level of peripheral blood B lymphocytes in patients with gynecologic malignanciesCancer, 2000
- The IgG1/G2 subclass shift – a sensitive, tissue non-specific marker for malignancy. Diagnostic performance with squamous cell carcinoma of the head and neckBritish Journal of Cancer, 1999
- 1997 update of recommendations for the use of tumor markers in breast and colorectal cancer. Adopted on November 7, 1997 by the American Society of Clinical Oncology.Journal of Clinical Oncology, 1998
- Selective decrease in serum immunoglobulin G1: A tissue nonspecific tumor marker detecting early stages of gynecologic malignant disease with high efficiencyCancer, 1996
- A novel method for monitoring high-risk breast cancer with tumor markers: CA 15.3 compared to CEA and TPAAnnals of Oncology, 1993
- Immunohistochemical determination of estrogen and progesterone receptor content in human breast cancerPathology - Research and Practice, 1993
- A Decrease in Reactive Disulfide Bonds of Serum IgG Signals a Characteristic Change in the IgG Subclass Pattern of Rats Bearing Experimental TumorsInternational Archives of Allergy and Immunology, 1993
- Clinical Applications of Serum Tumor MarkersAnnals of Internal Medicine, 1991
- Labile Disulfide Bonds and Free Thiol Groups in Human IgG I.International Archives of Allergy and Immunology, 1986
- Labile Disulfide Bonds and Free Thiol Groups in Human IgG II.International Archives of Allergy and Immunology, 1986